1. Pink Sheet

US FDA Could Miss User Fee Spending Triggers With House FY 2026 Funding

 
• By Sarah Karlin-Smith and Derrick Gingery

FDA employees are concerned that while the budget authority total proposed for fiscal year 2026 meets the user fee appropriations' triggers, the FDA could have trouble meeting allocation triggers without cuts to non-review work.

Sign that reads "Warning! Trigger"
The House FY 2026 FDA appropriations bill could force non-user fee program cuts to ensure minimum spending levels are met, agency sources told the Pink Sheet. (Shutterstock)
Key Takeaways
  • The FDA may have to cut some non-user fee program work to hit its user fee spending triggers if the FY 2026 House appropriations bill is enacted, agency sources told the Pink Sheet.

The US Food and Drug Administration may be forced to cut spending in non-user fee programs to ensure it can...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Legislation